Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes.

Freeman-Keller M, Kim Y, Cronin H, Richards A, Gibney G, Weber JS.

Clin Cancer Res. 2016 Feb 15;22(4):886-94. doi: 10.1158/1078-0432.CCR-15-1136. Epub 2015 Oct 7.

2.

Vaccine immunotherapy in lung cancer: Clinical experience and future directions.

Freeman-Keller M, Goldman J, Gray J.

Pharmacol Ther. 2015 Sep;153:1-9. doi: 10.1016/j.pharmthera.2015.05.004. Epub 2015 May 16. Review.

PMID:
25989231
3.

Anti-programmed death receptor 1 immunotherapy in melanoma: rationale, evidence and clinical potential.

Freeman-Keller M, Weber JS.

Ther Adv Med Oncol. 2015 Jan;7(1):12-21. doi: 10.1177/1758834014551747. Review.

Supplemental Content

Loading ...
Support Center